With decades of successful expertise in all areas of strategic business, product development, manufacturing, and international commercialization, MEXACARE supports pharmaceutical and diagnostic companies that are also active in gene expression profiling, differential diagnostics, and laboratory diagnostics. For more than 30 years, our team has been working with various, extremely competent and successful ex-Quidel top managers and company founders in the „biotech nucleus California“, who, through the Windarmere Venture Partners, have founded about 40 companies.
One of these companies, Prometheus Laboratories, which due to its unique „Rx/Dx Business Model“, represents a new „gold standard“ in the diagnosis of and individualized therapy for Chronic Inflammatory Bowel Disease (IBD) in the USA. As a result, Prometheus Laboratories has become the fastest-growing life science company in the USA (Inc Magazine – „The Inc 500“ and Deloitte & Touche Fast 50 Competition).
Further affiliated companies, in which we are or were active in management or as consultants, are the start-up Proprius Pharmaceuticals (sold to Cypress Bioscience) as well as acting as consultants for Metrika and AviaraDx.
Due to our extensive contacts in diagnostics and various pharmaceutical fields on both sides of the Atlantic, MEXACARE sees itself as experienced management consultants to our clients. We accompany the top management in strategic decisions: innovation management, the realization of market and expansion strategies, and the development and evaluation of portfolio strategies.